| The role of “anti-inflammatory” cytokines in axon regeneration PM Vidal, E Lemmens, D Dooley, S Hendrix Cytokine & growth factor reviews 24 (1), 1-12, 2013 | 119 | 2013 |
| Immunopharmacological intervention for successful neural stem cell therapy: New perspectives in CNS neurogenesis and repair D Dooley, P Vidal, S Hendrix Pharmacology & therapeutics 141 (1), 21-31, 2014 | 102 | 2014 |
| Cell-based delivery of interleukin-13 directs alternative activation of macrophages resulting in improved functional outcome after spinal cord injury D Dooley, E Lemmens, T Vangansewinkel, D Le Blon, C Hoornaert, ... Stem cell reports 7 (6), 1099-1115, 2016 | 79 | 2016 |
| Macrophage phagocytosis after spinal cord injury: when friends become foes J Van Broeckhoven, D Sommer, D Dooley, S Hendrix, AJPM Franssen Brain 144 (10), 2933-2945, 2021 | 69 | 2021 |
| Mast cells protect from post-traumatic spinal cord damage in mice by degrading inflammation-associated cytokines via mouse mast cell protease 4 S Nelissen, T Vangansewinkel, N Geurts, L Geboes, E Lemmens, ... Neurobiology of disease 62, 260-272, 2014 | 65 | 2014 |
| Functional hydrogels as therapeutic tools for spinal cord injury: New perspectives on immunopharmacological interventions CM Walsh, JK Wychowaniec, DF Brougham, D Dooley Pharmacology & therapeutics 234, 108043, 2022 | 42 | 2022 |
| Intracerebral transplantation of interleukin 13-producing mesenchymal stem cells limits microgliosis, oligodendrocyte loss and demyelination in the cuprizone mouse model D Le Blon, C Guglielmetti, C Hoornaert, A Quarta, J Daans, D Dooley, ... Journal of neuroinflammation 13, 1-20, 2016 | 38 | 2016 |
| Evaluating rodent motor functions: Which tests to choose? LM Schönfeld, D Dooley, A Jahanshahi, Y Temel, S Hendrix Neuroscience & Biobehavioral Reviews 83, 298-312, 2017 | 31 | 2017 |
| Mast cells promote scar remodeling and functional recovery after spinal cord injury via mouse mast cell protease 6 T Vangansewinkel, N Geurts, K Quanten, S Nelissen, S Lemmens, ... The FASEB Journal 30 (5), 2040-2057, 2016 | 30 | 2016 |
| Alterations in circulating lymphoid cell populations in systemic small vessel vasculitis are non-specific manifestations of renal injury B Fazekas, A Moreno-Olivera, Y Kelly, P O'hara, S Murray, A Kennedy, ... Clinical & Experimental Immunology 191 (2), 180-188, 2018 | 27 | 2018 |
| In vivo interleukin-13-primed macrophages contribute to reduced alloantigen-specific T cell activation and prolong immunological survival of allogeneic mesenchymal stem cell … CJ Hoornaert, E Luyckx, K Reekmans, M Dhainaut, C Guglielmetti, ... Stem Cells 34 (7), 1971-1984, 2016 | 27 | 2016 |
| Long-term motor deficits after controlled cortical impact in rats can be detected by fine motor skill tests but not by automated gait analysis LM Schönfeld, A Jahanshahi, E Lemmens, S Schipper, D Dooley, ... Journal of neurotrauma 34 (2), 505-516, 2017 | 23 | 2017 |
| HDAC3 inhibition promotes alternative activation of macrophages but does not affect functional recovery after spinal cord injury S Sanchez, S Lemmens, P Baeten, D Sommer, D Dooley, S Hendrix, ... Experimental Neurobiology 27 (5), 437, 2018 | 21 | 2018 |
| ADAM17-deficiency on microglia but not on macrophages promotes phagocytosis and functional recovery after spinal cord injury D Sommer, I Corstjens, S Sanchez, D Dooley, S Lemmens, ... Brain, behavior, and immunity 80, 129-145, 2019 | 19 | 2019 |
| Mouse mast cell protease 4 suppresses scar formation after traumatic spinal cord injury T Vangansewinkel, S Lemmens, N Geurts, K Quanten, D Dooley, G Pejler, ... Scientific reports 9 (1), 3715, 2019 | 16 | 2019 |
| Interleukin-25 is detrimental for recovery after spinal cord injury in mice D Dooley, E Lemmens, P Ponsaerts, S Hendrix Journal of Neuroinflammation 13, 1-6, 2016 | 12 | 2016 |
| An in vitro and ex vivo analysis of the potential of GelMA hydrogels as a therapeutic platform for preclinical spinal cord injury CM Walsh, JK Wychowaniec, L Costello, DF Brougham, D Dooley Advanced Healthcare Materials 12 (26), 2300951, 2023 | 11 | 2023 |
| Motor rehabilitation as a therapeutic tool for spinal cord injury: New perspectives in immunomodulation CM Walsh, K Gull, D Dooley Cytokine & growth factor reviews 69, 80-89, 2023 | 11 | 2023 |
| Macrophage-based delivery of interleukin-13 improves functional and histopathological outcomes following spinal cord injury J Van Broeckhoven, C Erens, D Sommer, E Scheijen, S Sanchez, ... Journal of neuroinflammation 19 (1), 102, 2022 | 8 | 2022 |
| Stress pathway modulation is detrimental or ineffective for functional recovery after spinal cord injury in mice S Lemmens, S Nelissen, D Dooley, N Geurts, EMJ Peters, S Hendrix Journal of Neurotrauma 37 (3), 564-571, 2020 | 7 | 2020 |
